PhaseBio Pharmaceuticals Inc
- Raised $26 million (2018)
- 13 clinical trials
- Research grants: $6.4 million
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Sarepta Therapeutics, Inc.
Nasdaq: SRPT
- Raised $400 million (2020)
- 53 clinical trials, 14 active
- 1 FDA-registered drug site
Cel Sci Corp
NYSE: CVM
- Raised $78,000 (2018)
- 2 clinical trials
- Research grants: $4.1 million
iotaMotion, Inc.
- Raised $1.9 million (2026)
- 4 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $8 million
Exact Sciences Corp
Nasdaq: EXAS
- Raised $8.2 million (2009)
- 32 clinical trials, 7 active
- FDA-cleared or approved devices
Cytovale Inc.
- Raised $16 million (2022)
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $4.3 million
Civatech Oncology, Inc.
- Raised $7.9 million (2021)
- 6 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $20 million
Kiniksa Pharmaceuticals International, plc
Nasdaq: KNSA
- Raised $8.8 million (2020)
- 14 clinical trials, 5 active
- Founded 2015
Silence Therapeutics plc
Nasdaq: SLN
- Raised $45 million (2021)
- 8 clinical trials, 1 active
- Founded 1994
ReShape Weightloss Inc.
- Raised $2.8 million (2018)
- 10 clinical trials
- Research grants: $2.6 million
Oculogica, Inc.
- Raised $7.6 million (2024)
- 6 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $1.1 million
MediBeacon Inc.
- Raised $16 million (2025)
- 12 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $363,008
Imbed Biosciences, Inc
- Raised $3.5 million (2023)
- 2 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $7.2 million
Abcuro, Inc.
- Raised $80 million (2025)
- 4 clinical trials, 1 active
- Research grants: $590,634
- Founded 2015
CytomX Therapeutics, Inc.
Nasdaq: CTMX
- Raised $30 million (2023)
- 9 clinical trials, 2 active
- Research grants: $468,956
- Founded 2010
Elutia Inc.
Nasdaq: ELUT
- Raised $11 million (2023)
- 14 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2015
Materna Medical Inc
- Raised $11 million (2025)
- 4 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $4.3 million
Beyond Air, Inc.
Nasdaq: XAIR
- Raised $21 million (2024)
- 10 clinical trials
- FDA-cleared or approved devices
- Founded 2015
Illumina, Inc.
Nasdaq: ILMN
- 17 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $8.9 million
Align Technology Inc
Nasdaq: ALGN
- Raised $72 million (2009)
- 6 clinical trials, 2 active
- FDA-cleared or approved devices
Showing 140 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences